International legal practice Osborne Clarke has advised Creo Medical Group plc on its entry into a binding agreement for the sale of 51% of the issued share capital of wholly owned subsidiary Creo Medical S.L.U. ("Creo Europe") to endoscopic medical device manufacturer Micro-Tech.
Creo Europe manufactures and distributes specialist Gastroenterology, Urology and Endoscopy products to healthcare providers across Europe, with a product range including Creo's own manufactured products, Creo-branded (third-party manufactured) products, and third-party branded (i.e. distributed) products, predominantly in the major European markets.
More information can be found in this RNS announcement.
A multijurisdictional Osborne Clarke corporate team advised on this transaction, led by Counsel Sara Barona, Partner David Miranda and Associate Pilar Diaz in Spain, along with Partner David Ferris and Associate Director James Mackay in the UK.
Osborne Clarke has a market-leading international corporate/M&A practice, with a strong track record of providing highly sophisticated advice to both buy-side and sell-side on cutting-edge issues, across multiple service lines. The team has experience advising a varied range of clients, from global businesses to fast-growth start-ups and market challengers.
Corporate communications and press contacts
Connect with one of our experts
